Market Closed -
Bombay S.E.
06:00:50 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
74.48
INR
|
+0.03%
|
|
-3.90%
|
-6.03%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,762
|
4,360
|
1,737
|
10,200
|
18,645
|
10,341
|
Enterprise Value (EV)
1 |
5,409
|
4,168
|
1,413
|
7,874
|
13,391
|
7,380
|
P/E ratio
|
9.95
x
|
5.71
x
|
3.73
x
|
5.07
x
|
4.89
x
|
20.4
x
|
Yield
|
1.49%
|
2.96%
|
7.43%
|
2.53%
|
2.31%
|
1.25%
|
Capitalization / Revenue
|
0.77
x
|
0.54
x
|
0.22
x
|
1
x
|
1.12
x
|
0.88
x
|
EV / Revenue
|
0.72
x
|
0.51
x
|
0.18
x
|
0.77
x
|
0.8
x
|
0.62
x
|
EV / EBITDA
|
5.47
x
|
4.12
x
|
2.08
x
|
2.68
x
|
2.55
x
|
9.96
x
|
EV / FCF
|
26.2
x
|
-12.6
x
|
2.73
x
|
4.94
x
|
4.65
x
|
-45.5
x
|
FCF Yield
|
3.82%
|
-7.94%
|
36.6%
|
20.2%
|
21.5%
|
-2.2%
|
Price to Book
|
1.47
x
|
0.96
x
|
0.36
x
|
1.5
x
|
1.81
x
|
0.99
x
|
Nbr of stocks (in thousands)
|
171,999
|
171,999
|
171,999
|
171,999
|
171,999
|
171,999
|
Reference price
2 |
33.50
|
25.35
|
10.10
|
59.30
|
108.4
|
60.12
|
Announcement Date
|
7/26/18
|
7/8/19
|
8/24/20
|
9/1/21
|
8/29/22
|
9/2/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
7,478
|
8,102
|
8,031
|
10,195
|
16,719
|
11,813
|
EBITDA
1 |
989.6
|
1,012
|
680.6
|
2,938
|
5,244
|
740.8
|
EBIT
1 |
900.4
|
901.3
|
567.1
|
2,823
|
5,087
|
559.3
|
Operating Margin
|
12.04%
|
11.12%
|
7.06%
|
27.69%
|
30.43%
|
4.73%
|
Earnings before Tax (EBT)
1 |
878
|
1,135
|
542.1
|
2,678
|
5,106
|
699.7
|
Net income
1 |
579
|
763.5
|
466.6
|
2,012
|
3,811
|
506.7
|
Net margin
|
7.74%
|
9.42%
|
5.81%
|
19.74%
|
22.79%
|
4.29%
|
EPS
2 |
3.366
|
4.439
|
2.710
|
11.70
|
22.16
|
2.946
|
Free Cash Flow
1 |
206.6
|
-330.8
|
517.4
|
1,594
|
2,882
|
-162.2
|
FCF margin
|
2.76%
|
-4.08%
|
6.44%
|
15.64%
|
17.24%
|
-1.37%
|
FCF Conversion (EBITDA)
|
20.88%
|
-
|
76.02%
|
54.25%
|
54.97%
|
-
|
FCF Conversion (Net income)
|
35.69%
|
-
|
110.88%
|
79.21%
|
75.63%
|
-
|
Dividend per Share
2 |
0.5000
|
0.7500
|
0.7500
|
1.500
|
2.500
|
0.7500
|
Announcement Date
|
7/26/18
|
7/8/19
|
8/24/20
|
9/1/21
|
8/29/22
|
9/2/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
353
|
192
|
324
|
2,325
|
5,254
|
2,960
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
207
|
-331
|
517
|
1,594
|
2,882
|
-162
|
ROE (net income / shareholders' equity)
|
16%
|
18%
|
9.97%
|
34.7%
|
44.6%
|
4.88%
|
ROA (Net income/ Total Assets)
|
10.1%
|
9.31%
|
5.39%
|
22.8%
|
29.1%
|
2.73%
|
Assets
1 |
5,721
|
8,198
|
8,649
|
8,821
|
13,078
|
18,586
|
Book Value Per Share
2 |
22.80
|
26.50
|
28.00
|
39.50
|
59.90
|
60.70
|
Cash Flow per Share
2 |
0.3800
|
3.160
|
3.180
|
16.40
|
35.60
|
22.00
|
Capex
1 |
317
|
194
|
294
|
245
|
272
|
445
|
Capex / Sales
|
4.24%
|
2.39%
|
3.66%
|
2.4%
|
1.63%
|
3.77%
|
Announcement Date
|
7/26/18
|
7/8/19
|
8/24/20
|
9/1/21
|
8/29/22
|
9/2/23
|
|
1st Jan change
|
Capi.
|
---|
| -6.03% | 154M | | -1.20% | 66.01B | | +47.62% | 41.76B | | +15.99% | 38.66B | | +4.25% | 32.28B | | +8.78% | 19.57B | | +12.32% | 16.77B | | +17.69% | 15.08B | | +8.31% | 14.83B | | -14.59% | 13.95B |
Other Commodity Chemicals
|